Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 22 • 04:00PM ET

16.35

-0.25 -1.51 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ZURA COGT AUPH KYTX ARQT

| Held by: VTI VXF IWC ITOT TMSL DFAS TMED DFMC BMED TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.82	Insider Own	11.68%	Shs Outstand	52.57M	Perf Week	-7.84%
Market Cap	859.45M	Forward P/E	-	EPS next Y	-3.11	Insider Trans	-4.93%	Shs Float	46.42M	Perf Month	10.85%
Enterprise Value	779.64M	PEG	-	EPS next Q	-0.62	Inst Own	56.99%	Short Float	12.35%	Perf Quarter	10.47%
Income	-84.74M	P/S	14324.17	EPS this Y	45.93%	Inst Trans	18.80%	Short Ratio	4.04	Perf Half Y	-7.05%
Sales	0.06M	P/B	5.90	EPS next Y	1.62%	ROA	-71.09%	Short Interest	5.73M	Perf YTD	-9.97%
Book/sh	2.77	P/C	10.46	EPS next 5Y	21.02%	ROE	-88.76%	52W High	24.27 -32.63%	Perf Year	318.16%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-120.51%	52W Low	3.43 376.50%	Perf 3Y	-97.73%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-283.05%	Volatility	9.52% 10.72%	Perf 5Y	-99.78%
Dividend TTM	-	EV/Sales	12994.00	EPS Y/Y TTM	-1121.44%	Oper. Margin	-134164.41%	ATR (14)	1.61	Perf 10Y	-99.82%
Dividend Ex-Date	-	Quick Ratio	7.66	Sales Y/Y TTM	-86.62%	Profit Margin	-143627.12%	RSI (14)	47.87	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.66	EPS Q/Q	21.93%	SMA20	-4.48%	Beta	0.83	Target Price	46.18
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	4.81%	Rel Volume	0.93	Prev Close	16.60
Employees	33	LT Debt/Eq	0.03	Earnings	May 13 BMO	SMA200	8.37%	Avg Volume	1.42M	Price	16.35
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	1,317,192	Change	-1.51%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)